BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Press Releases

  Boundless Bio to Participate in the Leerink Global Healthcare Conference

  February 26, 2025

   · 

  1 min read
• Press Releases

  Cognition Therapeutics Successfully Passes Pre-defined Futility Analysis of Phase 2 Study of Oral Zervimesine (CT1812) in Geographic Atrophy

  February 26, 2025

   · 

  7 min read
• Press Releases

  Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Business Update

  February 26, 2025

   · 

  21 min read
• Press Releases

  Zomedica to Report Fourth Quarter and Full Year 2024 Financial Results with a Business Update on March 13th at 4:30 p.m. ET

  February 26, 2025

   · 

  2 min read
• Press Releases

  CytoSorbents to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

  February 26, 2025

   · 

  5 min read
• Press Releases

  CitiusTech Launches CitiusTech HealthSPARX, A Real-World Data Platform for Life Sciences Organizations

  February 26, 2025

   · 

  2 min read
• Press Releases

  Kairos Pharma Presents Preclinical Data on its Investigational Compounds KROS 101 and KROS 401 Further Supporting Both Compounds’ Potential as Therapeutics for Melanoma and Glioblastoma

  February 26, 2025

   · 

  5 min read
• Press Releases

  Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2024 Results

  February 26, 2025

   · 

  29 min read
• Press Releases

  Camizestrant demonstrated highly statistically significant and clinically meaningful improvement in progression-free survival in 1st-line advanced HR-positive breast cancer with an emergent ESR1 tumor mutation in SERENA-6 Phase III trial

  February 26, 2025

   · 

  10 min read
• Press Releases

  Pyxis Oncology Granted FDA Fast Track Designation for PYX-201 Monotherapy in Patients with Recurrent or Metastatic Head and Neck Cancer

  February 26, 2025

   · 

  6 min read